Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Renal Protection in Infective Endocarditis
NCT02698930Unknown
- Sponsor
- Yonsei University
- Start
- Aug 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Yonsei University. Primary endpoint: Incidence of acute kidney injury at 1 week. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02698930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698930.